Blog Home



Popular tags

BBTS2017: Science, Diagnostics and Technology Sessions 

by Julie Staves, Blood Transfusion Lab Manager, John Radcliffe Hospital

I’m looking forward to both sessions within the science, diagnostics and technology theme at the BBTS Annual Conference this year. 

The sessions are focusing on different aspects of transfusion which should be of interest to lots of different groups from laboratory managers to transfusion medical staff to transfusion practitioners.

The morning session is looking at current trends which influence the supply chain. Chris Elliott will be giving us an update on using remote issue in a smaller hospital which is some distance away from the main laboratory site. I’m keen to hear how this has permitted him to look at the staffing required at this site and also how it’s being used out of hours. I’m sure there are a number of us with a similar set up who are keen to see how someone else has approached the problem. The 30 minute rule has long been an issue and I know I for one was looking forward to the long awaited changes. I definitely felt a bit deflated when they were released in 2016 as they are not especially user friendly. 

Kerry Dowling will provide us with an overview of the changes and will also look at why the take up of implementation of these changes as been poor. 

In the afternoon session, we are focusing on red cell antibodies. We are lucky to have Mark Yazer who is over from the US, he is going to present an interactive session focusing on anti-D sensitisation when you transfuse an RhD neg patient with RhD positive products. Mark is an excellent speaker and I’m sure it will be an enjoyable presentation. Watch out as Mark always includes a reference to Ipswich Town Football team! 

Many of us are now facing the challenge of providing red cells for patients receiving monoclonal antibodies as part of their on-going treatment, these interact with reagent red cells so making the usual pre-transfusion compatibility testing difficult. Mark Williams will be giving us an insight to the best strategies to employ to ensure the red cells we are providing as suitable in these difficult cases. 

Like last year both sessions will also have 2 short presentations selected from submitted abstracts, the topics for these are yet known, but I always looks forward to hearing who’ll be presenting and on what exciting topic.

I hope to see many of you at the science, diagnostic and technology sessions. I know its difficult to fit all the exciting presentations in and there will be times when you can’t be in 2 places at once (I too have that problem) but even if you pop into the session I’m sure you’ll learn something useful for your day to day working.

See you there, 


Your Comments

21 Feb 2020
2:33 am